Study Analysis Several Types Of Vaccine Covid-19 That Will Be Used In Indonesia
Article Sidebar
Main Article Content
Abstract
At the end of 2019, there was a pandemic that originated in Wuhan, China. This pandemic is known as the corona virus / COVID-19. COVID-19 itself is caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). In Indonesia alone, COVID-19 cases have reached 1.17 million and those who died have reached 31,976 people. From this case, experts are racing to find this COVID-19 vaccine. The COVID-19 vaccine itself is expected to control the spread of the virus in the world. This review article aims to discuss the various types of vaccines that will be used in Indonesia in terms of types, methods of action, efficacy, specificity, sensitivity, dosage, and side effects. The results of the review article show that vaccines are one of the most effective and economical methods. Various studies have been carried out by several experts from around the world to develop a vaccine for COVID-19. Each vaccine used has the same goal, namely to control the spread of the COVID-19 virus which is currently still a pandemic around the world. Based on the results of the review article, it can be concluded that all types of vaccines have their respective advantages and disadvantages. Thus, the community will not feel worried and are more confident in determining what kind of vaccine will be taken.
Article Details
References
Astuti, N. P., Nugroho, E. Z., Lattu, J. C., Potempu, I. R., & Swandana, D. A. (2021). PERSEPSI MASYARAKAT TERHADAP PENERIMAAN VAKSINASI COVID-19: LITERATURE REVIEW. Jurnal Keperawatan, 569-580.
Baden, L., R, E., H, M., Essink, B., Kotloff, K., Frey, S., et al. (2020). Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. New England Journal of Medicine, 403-416.
BPPSDMK KEMENKES 2015. (2015). Buku Ajar Imunisasi. Jakarta: https://bppdmsk.kemenkes.go.id/pusdiksdmk/wpcontent/uploads/2017/10/03Buku-Ajar-Imunisasi-06-10-2015-small.
CDC & Neird . (2019). Moderna Vaccine Administration : Intramuscular (IM) Injections : Adult 19 years of age and older . CDC, 19-20.
F, D. (2019). Fact Sheet for Healthcare Providers. bioMerieux, Inc,: VIDAS SARS-COV2, 1-22.
FDA . (2012). FDA Vaccines and Related Biological Product Advisory Committee Meeting. FDA Briefing Moderna Covid-19 Vaccine , 1-30.
Hairunisa, N., & Amalia, H. (2020). Penyakit virus corona baru 2019 (COVID-19). Jurnal Biomedika dan Kesehatan, 90-100.
Handayani , D., Hadi, D., Isbaniah, F., Burhan, E., & Agustin, H. (2019). Penyakit Virus Corona 2019. Jurnal Respirologi Indonesia, 119-129.
KEMENKES. (2020). FAQ VAKSINASI COVID . Jakarta: Kesmas.kemkes.go.id.
Levani, Y., Prastya, A. D., & Mawaddatunnadila, S. (2021). Coronavirus Disease 2019 (COVID-19): Patogenesis, Manifestasi Klinis dan Pilihan Terapi. Jurnal Kedokteran dan Kesehatan , 44-57.
Nicole, L., & M., D. (2020). Developing Covid-19 Vaccines at Pandemic Speed. New England Journal, 1-5.
Nugroho, S. A., & Hidayat, I. (2021). Efektivitas Dan Keamanan Vaksin Covid-19 : Studi Refrensi. Jurnal Keperawatan Profesional (JKP), Vol. 9.
Ophinni , Y., Hasibuan, A., Widhani, A., Maria S, Koesnoe, S., & et al. (2020). COVID-19 Vaccines : Current Status and Implication for Use in Indonesia. Acta Med Indonesia, 52, Vol.4.
Rahayu, R., & Sensusiyati. (2021). VAKSIN COVID 19 DI INDONESIA : ANALISIS BERITA HOAX. INTELEKTIVA : JURNAL EKONOMI, SOSIAL & HUMANIORA, 39-49.
Wahidah, I., Septiadi, M. A., Rafqie, A. M., Hartono, N. S., & Athallah, R. (2020). Pandemik Covid-19: Analisis Perencanaan Pemerintah dan Masyarakat dalam Berbagai Upaya Pencegahan. Jurnal Manajemen dan Organisasi (JMO), 179-188.
Zhang, J., & et, a. (2020). Progress and Prospects on Vaccine Development agains SARS-CoV-2 . Vaccines 2020, 153, vol. 8.